Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells.
Front Cell Dev Biol
; 10: 852812, 2022.
Article
in En
| MEDLINE
| ID: mdl-35392170
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Front Cell Dev Biol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: